XERS - Xeris Pharmaceuticals EPS misses by $0.32 beats on revenue August, 06 2019 04:53 PM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (NASDAQ:XERS): Q2 GAAP EPS of -$1.28 misses by $0.32.More news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...